FORTE BIOSCIENCES INC (FBRX) Stock Income Statement
NASDAQ:FBRX - Nasdaq - US34962G2084 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 40.00K | |||
| Operating Expenses | 32.49M | 13.90M | 21.49M | 46.28M | 61.55M | |||
| Research and Development | 21.86M | 5.59M | 13.85M | 42.06M | 45.30M | |||
| Selling, General, and Administrative Expenses | 10.62M | 8.30M | 7.63M | 4.22M | 16.25M | |||
| Operating Income | -32.49M | -13.90M | -21.49M | -46.28M | -61.51M | |||
| Interest Income/Expense | 1.12M | N/A | N/A | N/A | -2.26M | |||
| Other Income/Expense | -114.00K | 20.00K | -220.00K | -210.00K | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 1.44M | |||
| Income Before Taxes | -31.48M | -13.88M | -21.71M | -46.49M | -63.52M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -31.48M | -13.88M | -21.71M | -46.49M | -63.52M | |||
| EBITDA | -32.48M | N/A | -21.45M | -46.23M | -60.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.00 | -0.80 | -1.55 | -6.32 | -40.20 | |||
| Non GAAP EPS | N/A | N/A | -38.50 | -419.75 | -1.03K | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -158800.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -153775.00% | |||
All data in USD